ProCE Banner Series

JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps

The treatment landscape for alopecia areata is shifting with the recent FDA approval of two JAK inhibitors and a robust development pipeline. Join us for this multiactivity program to hear the latest insights about pathophysiology, diagnosis, management, and much more from renowned dermatology experts.

  AAPA
  | AMA
  | ANCC
Who Should Attend

The intended target audience for this program is US dermatologists and NPs/PAs who treat patients with AA.

All Events

JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps

Past Events

July

11

2023

5:30 PM - 6:30 PM Eastern Time (ET)

Virtual

August

23

2023

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

September

12

2023

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

September

18

2023

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

October

23

2023

2:00 PM - 3:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Brittany Craiglow, MD

Associate Adjunct Professor
Department of Dermatology
Yale School of Medicine
New Haven, Connecticut

ProCE Banner Faculty
Maryanne Makredes Senna, MD, FAAD

Assistant Professor of Dermatology 
Harvard Medical School 
Boston, Massachusetts 
Director, Lahey Hair Loss Center of Excellence
Lahey Hospital and Medical Center 
Burlington, Massachusetts

ProCE Banner Faculty
Benjamin Ungar, MD

Assistant Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Topics

Welcome

Best Practices in Alopecia Areata Diagnosis and Classification

Management of Alopecia Areata

Patient-centered Care

Ask the Expert: Question and Answer Breakout Sessions

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Program Overview
The treatment landscape for alopecia areata is shifting with the recent FDA approval of a JAK inhibitor and a robust development pipeline. Join us for this multiactivity program to hear the latest insights about pathophysiology, diagnosis, management, and much more from renowned dermatology experts.

This program is intended for healthcare professionals.

Goal Statement
The goal of this program is for learners to demonstrate and improve their application of knowledge, clinical performance, and confidence in making treatment decisions to optimize the treatment of patients with AA. 

Target Audience
The intended target audience for this program is US dermatologists and NPs/PAs who treat patients with AA.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Formulate an accurate diagnosis and classification of AA based on multiple disease and patient factors
  • Detail factors that may predict a patient’s positive or negative response to JAK inhibitor therapy for AA
  • Evaluate patients with AA for treatment candidacy with JAK inhibitor therapy

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the National Alopecia Areata Foundation. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with the National Alopecia Areata Foundation.

Supported by an educational grant from Lilly.